Abstract:BCL11B is a transcription factor with six C 2 H 2 -type zinc-finger domains. Studies in mice have shown that Bcl11b plays essential roles in T cell development. Several germline heterozygous BCL11B variants have been identified in human patients with inborn errors of immunity (IEI) patients. Among these, two de novo mis-sense variants cause asparagine (N) to lysine (K) replacement in distinct zinc-finger domains, BCL11B N441K and BCL11B N807K . To elucidate the pathogenesis of the BCL11B N807K variant, we generated a mouse model of BCL11B N807K by inserting the corresponding mutation, Bcl11b N797K , into the mouse genome. In Bcl11b +/N797K mice, the proportion of immature CD4 − CD8 + single-positive thymocytes was increased, and the development of invariant natural killer cells was severely inhibited in a T-cell-intrinsic manner. Under competitive conditions, γδT cell development was outcompeted by control cells. Bcl11b N797K/N797K mice died within one day of birth. Recipient mice reconstituted with Bcl11b N797K/N797K fetal liver cells nearly lacked CD4 + CD8 + double-positive thymocytes, which was consistent with the lack of their emergence in culture from Bcl11b N797K/N797K fetal liver progenitors. Interestingly, Bcl11b N797K/N797K progenitors gave rise to aberrant c-Kit + and CD44 + cells both in vivo and in vitro . The increase in the proportion of immature CD8 single-positive thymocytes in the Bcl11b N797K mutants is caused, in part, by the inefficient activation of the Cd4 gene due to the attenuated function of the two Cd4 enhancers via distinct mechanisms. Therefore, we conclude that immunodeficient patient-derived Bcl11b N797K mutant mice elucidated a novel role for Bcl11b in driving the appropriate transition of CD4 − CD8 − into CD4 + CD8 + thymocytes.

A Bcl11bN797K variant isolated from an immunodeficient patient inhibits early thymocyte development in mice

A mutant BCL11B-N440K protein interferes with BCL11A function during T lymphocyte and neuronal development

Bcl11b prevents the intrathymic development of innate CD8 T cells in a cell intrinsic manner

Critical roles of Bcl11b in T‐cell development and maintenance of T‐cell identity

Bcl11b-A Critical Neurodevelopmental Transcription Factor-Roles in Health and Disease.

The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation

BCL11B depletion induces the development of highly cytotoxic innate T cells out of IL-15 stimulated peripheral blood αβ CD8+ T cells

The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development.

Bcl11b sustains multipotency and restricts effector programs of intestinal-resident memory CD8 + T cells

BCL11b interacts with RNA and proteins involved in RNA processing and developmental diseases

Kelch-like Protein 14 Promotes B-1a but Suppresses B-1b Cell Development

Bcl6-Independent In Vivo Development of Functional Type 1 Classical Dendritic Cells Supporting Tumor Rejection

Thymic Selection Can Compensate for Mutations Affecting T Cell Activation and Generate a Normal T Cell Repertoire in Mutant Mice

Dual role of BCL11B in T-cell malignancies

TNF-α–Dependent Hematopoiesis Following Bcl11b Deletion in T Cells Restricts Metastatic Melanoma

CARD11 regulates the thymic Treg development in an NF-κB-independent manner

Bcl11b and combinatorial resolution of cell fate in the T-cell gene regulatory network

Genomic deletion of Bcl6 differentially affects conventional dendritic cell subsets and compromises Tfh/Tfr/Th17 cell responses

BCL6 is required for the thymic development of TCRαβ + CD8αα + intraepithelial lymphocyte lineage

Bcl11b, a Novel GATA3-interacting Protein, Suppresses Th1 While Limiting Th2 Cell Differentiation